Sökning: onr:"swepub:oai:DiVA.org:umu-128137" >
Patient Heterogenei...
-
Hoogendoorn, MartineErasmus University Rotterdam
(författare)
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease : Are Current Models Suitable to Evaluate Personalized Medicine?
- Artikel/kapitelEngelska2016
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2016
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-128137
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-128137URI
-
https://doi.org/10.1016/j.jval.2016.04.002DOI
-
https://lup.lub.lu.se/record/d3980d87-6687-4483-b684-c0753eb85e46URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
OBJECTIVES: To assess how suitable current chronic obstructive pulmonary disease (COPD) cost-effectiveness models are to evaluate personalized treatment options for COPD by exploring the type of heterogeneity included in current models and by validating outcomes for subgroups of patients.METHODS: A consortium of COPD modeling groups completed three tasks. First, they reported all patient characteristics included in the model and provided the level of detail in which the input parameters were specified. Second, groups simulated disease progression, mortality, quality-adjusted life-years (QALYs), and costs for hypothetical subgroups of patients that differed in terms of sex, age, smoking status, and lung function (forced expiratory volume in 1 second [FEV1] % predicted). Finally, model outcomes for exacerbations and mortality for subgroups of patients were validated against published subgroup results of two large COPD trials.RESULTS: Nine COPD modeling groups participated. Most models included sex (seven), age (nine), smoking status (six), and FEV1% predicted (nine), mainly to specify disease progression and mortality. Trial results showed higher exacerbation rates for women (found in one model), higher mortality rates for men (two models), lower mortality for younger patients (four models), and higher exacerbation and mortality rates in patients with severe COPD (four models).CONCLUSIONS: Most currently available COPD cost-effectiveness models are able to evaluate the cost-effectiveness of personalized treatment on the basis of sex, age, smoking, and FEV1% predicted. Treatment in COPD is, however, more likely to be personalized on the basis of clinical parameters. Two models include several clinical patient characteristics and are therefore most suitable to evaluate personalized treatment, although some important clinical parameters are still missing.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Feenstra, Talitha LNational Institute for Public Health and the Environment (RIVM),University of Groningen
(författare)
-
Asukai, YumiIMS Health Sweden AB
(författare)
-
Briggs, Andrew HUniversity of Glasgow
(författare)
-
Borg, SixtenLund University,Lunds universitet,Hälsoekonomi,Forskargrupper vid Lunds universitet,Health Economics,Lund University Research Groups,Evidera Ltd,IHE – The Swedish Institute for Health Economics(Swepub:lu)med-sxb
(författare)
-
Dal Negro, Roberto WNational Center for Respiratory Pharmacoeconomics and Pharmacoepidemiology
(författare)
-
Hansen, Ryan NUniversity of Washington
(författare)
-
Jansson, Sven-ArneUmeå University,Umeå universitet,Yrkes- och miljömedicin,The OLIN Unit(Swepub:umu)svja0005
(författare)
-
Leidl, ReinerHelmholtz Zentrum München
(författare)
-
Risebrough, NancyICON Health Economics
(författare)
-
Samyshkin, YevgeniyIMS Health Sweden AB
(författare)
-
Wacker, Margarethe EHelmholtz Zentrum München
(författare)
-
Rutten-van Mölken, Maureen P M H
(författare)
-
Erasmus University RotterdamNational Institute for Public Health and the Environment (RIVM)
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Value in Health: Elsevier BV19:6, s. 800-8101098-30151524-4733
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Hoogendoorn, Mar ...
-
Feenstra, Talith ...
-
Asukai, Yumi
-
Briggs, Andrew H
-
Borg, Sixten
-
Dal Negro, Rober ...
-
visa fler...
-
Hansen, Ryan N
-
Jansson, Sven-Ar ...
-
Leidl, Reiner
-
Risebrough, Nanc ...
-
Samyshkin, Yevge ...
-
Wacker, Margaret ...
-
Rutten-van Mölke ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
-
och Hälso och sjukvå ...
- Artiklar i publikationen
-
Value in Health
- Av lärosätet
-
Umeå universitet
-
Lunds universitet